Nuvectis Pharma, Inc. NVCT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Nuvectis Pharma, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s current ratio?
- Nuvectis Pharma, Inc. (NVCT) reported current ratio of 2.3× in Q1 2026.
- How has Nuvectis Pharma, Inc.'s current ratio changed year-over-year?
- Nuvectis Pharma, Inc.'s current ratio decreased by 30.7% year-over-year, from 3.3× to 2.3×.
- What is the long-term trend for Nuvectis Pharma, Inc.'s current ratio?
- Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s current ratio has grown at a -0.3% compound annual growth rate (CAGR), from 2.4× to 2.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.